FAST-growing UK CBD, health and medical cannabis business the Alphagreen Group has launched £2m funding round with half of the fund-raise set to come from the Seedrs investment platform.
Alphagreen’s growth has been rapid with its initial B2C CBD marketplace now hosting over 150 brands as it expands its presence across Europe and into Asia.
It also recently launched the Nuoptima B2B platform featuring SEO ranking, social influencer, AdWords, email marketing, and cross-border distribution, with others, set to follow.
CEO & Co-Founder of Alexej Pikovsky said it is raising the cash based on a valuation of £10m with the £2m to be used used across its business streams.
He said: “The funds will be used to boost our international growth, continue our work with the best global brands, roll-out our business intelligence and growth platform and enter the medical cannabis space.”
Mr Pikovsky said Alphagreen had been contemplating a number of fund-raising avenues before settling on a private fund-raise, alongside Seedrs.
He said: “It’s a nice alternative to the public markets as you can also trade your investments on the Seedrs Secondary Market and it will allow us to continue to build our business in a long-term, sustainable way.”
The London-based Seedrs platform has some 500,000 active investors and taps into the emerging appetite for individual investment amongst a younger demographic.
Alphagreen.io is one of Europe’s leading CBD marketplaces and currently hosts 2,500 products and 150-plus brands. It has a presence in Germany and Sweden, Spain, Italy and France and Poland, with Hong Kong and Japan set to follow.
Writing on LinkedIn Mr Pikovsky said: “We’re crowdfunding one of the biggest rounds in the health space this year! Become an investor in Alphagreen and be part of the revolution.”
The Alphagreen Group also operates a German subsidiary for the import and distribution of medical cannabis.
